Close Menu

CHICAGO (GenomeWeb) – Analytics from "big data" in healthcare has been around for at least a decade, with backers often trumpeting it as a "game changer" or "revolutionary."

While IBM may be part of that hype machine, Anil Jain, vice president and chief health informatics officer of IBM Watson Health offered a sobering reality check with seven simple words. "How much difference has it made in health?" Jain asked rhetorically at this week's Cleveland Clinic Medical Innovation Summit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.

Jul
09
Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program.